Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$40.66 - $53.03 $44,725 - $58,333
-1,100 Reduced 11.7%
8,300 $0
Q2 2022

Aug 04, 2022

BUY
$40.85 - $77.67 $44,935 - $85,437
1,100 Added 13.25%
9,400 $5,000
Q1 2022

Apr 14, 2022

SELL
$59.95 - $92.06 $725,395 - $1.11 Million
-12,100 Reduced 59.31%
8,300 $15,000
Q4 2021

Jan 18, 2022

BUY
$81.07 - $121.29 $1.62 Million - $2.43 Million
20,000 Added 5000.0%
20,400 $31,000
Q3 2021

Oct 26, 2021

SELL
$101.99 - $166.36 $30,597 - $49,908
-300 Reduced 42.86%
400 $0
Q2 2021

Jul 19, 2021

BUY
$141.6 - $179.06 $42,480 - $53,718
300 Added 75.0%
700 $11,000
Q1 2021

Apr 26, 2021

SELL
$132.81 - $182.18 $730,455 - $1 Million
-5,500 Reduced 93.22%
400 $0
Q3 2020

Oct 27, 2020

SELL
$114.09 - $145.51 $1.13 Million - $1.44 Million
-9,900 Reduced 62.66%
5,900 $78,000
Q2 2020

Jul 22, 2020

BUY
$89.45 - $129.85 $1.34 Million - $1.95 Million
15,000 Added 1875.0%
15,800 $85,000
Q1 2020

May 07, 2020

SELL
$70.23 - $144.31 $252,828 - $519,516
-3,600 Reduced 81.82%
800 $16,000
Q4 2019

Feb 06, 2020

BUY
$76.41 - $117.54 $328,563 - $505,422
4,300 Added 4300.0%
4,400 $6,000
Q2 2019

Aug 09, 2019

SELL
$58.04 - $66.99 $174,120 - $200,969
-3,000 Reduced 96.77%
100 $0
Q1 2019

May 10, 2019

BUY
$35.52 - $62.62 $106,560 - $187,860
3,000 Added 3000.0%
3,100 $20,000
Q4 2018

Feb 05, 2019

SELL
$35.43 - $56.29 $159,435 - $253,305
-4,500 Reduced 97.83%
100 $0
Q3 2018

Nov 07, 2018

SELL
$44.22 - $75.47 $88,440 - $150,940
-2,000 Reduced 30.3%
4,600 $2,000
Q2 2018

Aug 10, 2018

SELL
$72.38 - $92.5 $195,426 - $249,750
-2,700 Reduced 29.03%
6,600 $7,000
Q1 2018

May 11, 2018

BUY
$69.46 - $88.57 $569,572 - $726,274
8,200 Added 745.45%
9,300 $37,000
Q3 2017

Oct 17, 2017

BUY
$80.87 - $91.08 $88,957 - $100,188
1,100
1,100 $0

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $162M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.